KS
Therapeutic Areas
Avilex Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AVLX-144 | Acute Ischemic Stroke, Subarachnoid Hemorrhage | Phase 2 |
| 2nd Generation PSD-95 Inhibitors | Acute Neurological Conditions | Preclinical |
| PSD-95 PET Tracer | Clinical Biomarker | Preclinical |
| Cyclic Peptide PSD-95 Inhibitors | Acute Neurological Conditions | Lead Optimization |